Population
105 Taiwanese subjects including 15 healthy subjects, 12 patients with pancreatic ductal adenocarcinoma and…
Design
Cross-sectional
Authors
Loading...
May aid PDAC-DM detection in cross-sectional data; hypothesis-generating and requires prospective validation before clinical adoption.
Betatrophin combined with CA19-9 may serve as a highly accurate potential biomarker for pancreatic cancer-associated diabetes.
Susanto et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: